ウイルス不活化の世界市場:方法別(溶媒・活性剤処理、殺菌処理)、製品別(キット・試薬、サービス、ウイルス不活化システム・アクセサリ)、用途別(血液・血液製剤、細胞療法・遺伝子療法製品、幹細胞製品、細胞組織・細胞組織製品、ワクチン・治療薬)、エンドユーザー別(製薬・バイオテクノロジー企業、CRO (医薬品開発業務受託機関) 、学術研究機関)、地域別予測

Bizwit Research & Consultingが出版した調査資料(BZW80726)
◆英語タイトル:Global Viral Inactivation Market Size Study By Method (Solvent Detergent Method, Pasteurization) By Product (Kits and Reagents, Services, Viral Inactivation Systems and Accessories)by Application (Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, Vaccines and Therapeutics)by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes) and Regional Forecasts 2017-2025
◆商品コード:BZW80726
◆発行会社(調査会社):Bizwit Research & Consulting
◆発行日:2018年7月3日
◆ページ数:約80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥610,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本資料は、ウイルス不活化の世界市場について調べ、ウイルス不活化の世界規模、市場動向、市場環境、方法別(溶媒・活性剤処理、殺菌処理)分析、製品別(キット・試薬、サービス、ウイルス不活化システム・アクセサリ)分析、用途別(血液・血液製剤、細胞療法・遺伝子療法製品、幹細胞製品、細胞組織・細胞組織製品、ワクチン・治療薬)分析、エンドユーザー別(製薬・バイオテクノロジー企業、CRO (医薬品開発業務受託機関) 、学術研究機関)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・ウイルス不活化の世界市場概要
・ウイルス不活化の世界市場環境
・ウイルス不活化の世界市場動向
・ウイルス不活化の世界市場規模
・ウイルス不活化の世界市場規模:方法別(溶媒・活性剤処理、殺菌処理)
・ウイルス不活化の世界市場規模:製品別(キット・試薬、サービス、ウイルス不活化システム・アクセサリ)
・ウイルス不活化の世界市場規模:用途別(血液・血液製剤、細胞療法・遺伝子療法製品、幹細胞製品、細胞組織・細胞組織製品、ワクチン・治療薬)
・ウイルス不活化の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、CRO (医薬品開発業務受託機関) 、学術研究機関)
・ウイルス不活化の世界市場:地域別市場規模・分析
・ウイルス不活化の北米市場規模・予測
・ウイルス不活化のアメリカ市場規模・予測
・ウイルス不活化のヨーロッパ市場規模・予測
・ウイルス不活化のアジア市場規模・予測
・ウイルス不活化の日本市場規模・予測
・ウイルス不活化の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Viral Inactivation Market to reach USD 771.3 million by 2025.

Global Viral Inactivation Market valued approximately USD 319.2 million in 2016 is anticipated to grow with a healthy growth rate of more than 14.5% over the forecast period 2017-2025. Global rise in the number of chronic diseases like cancer, diabetes, autoimmune disorders, and other diseases has led to an increase in healthcare expenditure as well as increase in healthcare spending has mainly boosted the market for development of new & enhanced therapies to tackle the rise in these diseases. Increasing R&D innovation, drug discoveries, and FDA approvals leading to commercialization of new drugs has resulted in growth of the market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors&challenges which will define the future growth of the market. Additionally, the report shall also incorporate availableopportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

 By Method
 Solvent Detergent Method
 Pasteurization
 By Product
 Kits and Reagents
 Services
 Viral Inactivation Systems and Accessories
 by Application
 Blood & Blood Products
 Cellular & Gene Therapy Products
 Stem Cell Products
 Tissue & Tissue Products
 Vaccines and Therapeutics
 by End User
 Pharmaceutical and Biotechnology Companies
 Contract Research Organizations
 Academic Research Institutes
By Regions:
 North America
 U.S.
 Canada
 Europe
 UK
 Germany
 Asia Pacific
 China
 India
 Japan
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGAA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Viral Inactivation in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS
Chapter 1. Global Viral Inactivation Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
Chapter 4. Global Viral Inactivation Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Viral Inactivation Market, By Method
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Global Viral Inactivation Market, Sub Segment Analysis
5.3.1. Solvent Detergent Method

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Pasteurization
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Viral Inactivation Market, By Product
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Global Viral Inactivation Market, Sub Segment Analysis

6.1.1. Kits and Reagents

6.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.1.2. Services

6.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.1.3. Viral Inactivation Systems and Accessories

6.1.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.1.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Global Viral Inactivation Market, by Application
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Global Viral Inactivation Market, Sub Segment Analysis
7.3.1. Blood and Blood Products

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Cellular and Gene Therapy Products

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Stem Cell Products

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Tissue & Tissue Products

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.5. Vaccine and Therapeutics

7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Viral Inactivation Market, by End-User
8.1. Market Snapshot
8.2. Market Performance – Potential Model
8.3. Global Viral Inactivation Market, Sub Segment Analysis
8.3.1. Pharmaceutical & Biotechnology Companies

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Contract Research Organizations

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Academic Research Institutes

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 9. Global Viral Inactivation Market, by Regional Analysis
9.1. Viral Inactivation Market, Regional Market Snapshot (2015-2025)
9.2. North America Viral Inactivation Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3. Europe Viral Inactivation Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Viral Inactivation Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Rest of The World
9.5.1. South America
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Middle East and Africa
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Clean Cells (France)

10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Charles River Laboratories International, Inc. (U.S.)
10.3.3. Danaher Corporation (U.S.)
10.3.4. Merck KGAA (Germany
10.3.5. Parker Hannifin (U.S.)
10.3.6. Rad Source Technologies (U.S.)
10.3.7. Sartorius AG (Germany)
10.3.8. SGS S.A. (Switzerland)
10.3.9. Texcell, Inc. (France)
10.3.10. Viral Inactivated Plasma Systems SA (Switzerland)
10.3.11. WuXi PharmaTech (Cayman) Inc. (China)

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL VIRAL INACTIVATIONMARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL VIRAL INACTIVATIONMARKET
TABLE 3. YEARS CONSIDERED FOR THE STUDY
TABLE 4. EXCHANGE RATES CONSIDERED
TABLE 5. GLOBAL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 6. GLOBAL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 7. GLOBAL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 8. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 9. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. GLOBAL VIRAL INACTIVATIONMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. U.S. VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 46. U.S. VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. CANADA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 50. CANADA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 51. CANADA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. UK VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 55. UK VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 56. UK VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. GERMANY VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 60. GERMANY VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 61. GERMANY VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. ROE VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 65. ROE VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 66. ROE VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. CHINA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 70. CHINA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 71. CHINA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. INDIA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 75. INDIA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 76. INDIA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. JAPAN VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 80. JAPAN VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 81. JAPAN VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. ROAPAC VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 85. ROAPAC VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 86. ROAPAC VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. BRAZIL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 90. BRAZIL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 91. BRAZIL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. MEXICO VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 95. MEXICO VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 96. MEXICO VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. ROLA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 100. ROLA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 101. ROLA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROW VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 105. ROW VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 106. ROW VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW VIRAL INACTIVATIONMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)



FIG 1. GLOBAL VIRAL INACTIVATIONMARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL VIRAL INACTIVATIONMARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL VIRAL INACTIVATIONMARKET, KEY TRENDS 2016
FIG 5. GLOBAL VIRAL INACTIVATIONMARKET, GROWTH PROSPECTS 2017-2025
FIG 6. GLOBAL VIRAL INACTIVATIONMARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL VIRAL INACTIVATIONMARKET, PEST ANALYSIS
FIG 8. GLOBAL VIRAL INACTIVATIONMARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. GLOBAL VIRAL INACTIVATIONMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. GLOBAL VIRAL INACTIVATIONMARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA VIRAL INACTIVATIONMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE VIRAL INACTIVATIONMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC VIRAL INACTIVATIONMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA VIRAL INACTIVATIONMARKET 2015 & 2025 (USD BILLON)
FIG 36. GLOBAL VIRAL INACTIVATIONMARKET, COMPANY MARKET SHARE ANALYSIS (2016)






★調査レポート[ウイルス不活化の世界市場:方法別(溶媒・活性剤処理、殺菌処理)、製品別(キット・試薬、サービス、ウイルス不活化システム・アクセサリ)、用途別(血液・血液製剤、細胞療法・遺伝子療法製品、幹細胞製品、細胞組織・細胞組織製品、ワクチン・治療薬)、エンドユーザー別(製薬・バイオテクノロジー企業、CRO (医薬品開発業務受託機関) 、学術研究機関)、地域別予測] (コード:BZW80726)販売に関する免責事項を必ずご確認ください。
★調査レポート[ウイルス不活化の世界市場:方法別(溶媒・活性剤処理、殺菌処理)、製品別(キット・試薬、サービス、ウイルス不活化システム・アクセサリ)、用途別(血液・血液製剤、細胞療法・遺伝子療法製品、幹細胞製品、細胞組織・細胞組織製品、ワクチン・治療薬)、エンドユーザー別(製薬・バイオテクノロジー企業、CRO (医薬品開発業務受託機関) 、学術研究機関)、地域別予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆